JEFFREY KAHN: Open Payments
NPI 1639194822 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 10 payments from 8 companies in 2025. Trend: 2023 $3,234 · 2024 $303 · 2025 $1,184
Food & beverage: $784Consulting: $400
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $400 |
| Madrigal Pharmaceuticals | 2 | $296 |
| Boston Scientific Corporation | 1 | $170 |
| Gilead Sciences, Inc. | 1 | $122 |
| ABBVIE INC. | 1 | $95 |
| ORPHALAN INC | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 1 | $38 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, TheraSphere Administration Set, Livdelzi, MAVYRET, CUVRIOR, IQIRVO, Livmarli.
Industry payments across CA — which companies pay providers there.
